Histological Type. Morphological and Molecular Typing of breast Cancer. Nottingham Tenovus Primary Breast Cancer Study. Survival (%) Ian Ellis
|
|
- Victoria Chambers
- 5 years ago
- Views:
Transcription
1 Morphological and Molecular Typing of breast Cancer Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology, Nottingham University Hospitals NHS Trust Histological Type Survival (%) Histological type Tubular Tubular variant Lobular Cribriform Papillary Mucinous Medullary Ductal NST Long term survivors n = Consecutive series n = Short term survivors n = Dixon et al, Br J Surg 1985; 72: Nottingham Tenovus Primary Breast Cancer Study Histological type Excellent (>80% 10 year survival) Tubular, tubulo-lobular, invasive cribriform, mucinous Good (60-80% 10 year survival) Tubular mixed, alveolar lobular, mixed ductal NST & special type Moderate (50-60% 10 year survival) Medullary, atypical medullary, classical lobular, invasive papillary Poor (<50% 10 year survival) Ductal NST, solid lobular, lobular mixed, mixed ductal NST & lobular 1
2 Infiltrating Lobular Carcinoma Morphological features Composed of small regular cells identical to those seen in LCIS The cells are usually dissociated from each other and form single files and targetoid patterns around normal ducts and acini The following sub-types are recognised: classical, alveolar, solid, tubulo-lobular, mixed, pleomorphic NB 90% of the tumour must be of lobular pattern to be so classified NHS BSP EQA Scheme Subtype of invasive carcinoma Circulation NST Lobular Tubular Medullary Mucinous Mix Other Overall (No. cases) (66) (12) (9) (4) (9) (1) (2) (103) 902,911, ,922, ,941, ,952, ,971, , All NHS BSP EQA Scheme Subtype of invasive carcinoma Circulation NST Lobular Tubular Medullary Mucinous Mix Other Overall (No. cases) (66) (12) (9) (4) (9) (1) (2) (103) 902,911, ,922, ,941, ,952, ,971, , All Medullary Carcinoma Morphological features Sharply circumscribed soft, rounded tumour mass with pushing rather than infiltrating margin Interconnecting sheets of large, bizarre and pleomorphic carcinoma cells forming a syncytial network Stroma contains moderate to large numbers of lympho-plasmacytoid cells which do not intervene extensively between individual tumour cells In situ component insignificant Biological Importance of Tumour Type - Hereditary and Familial Breast Cancer Histopathological and genetic characteristics Invasive carcinomas of medullary type or with medullary features occur more frequently in familial and early-onset (< 35 years) cases - Rosen et al, 1992; Kollias et al, 1997 Medullary-like carcinomas are found significantly more frequently in BRCA-1 carriers than in BRCA-2 carriers and control populations - Marcus et al, 1996; Breast Cancer Linkage Consortium, 1997; Lakhani et al, 1998; Lakhani et al,
3 Hereditary and Familial Breast Cancer Histopathological, immunohistochemical and genetic characteristics Breast cancers in patients with BRCA1 germline mutations are more often negative for ER, PgR and HER-2 and positive for p53 protein The combined morphologic and immunohistochemical data can be used to predict the risk of a young patient harbouring a germline mutation in BRCA1 Round Case NST Tubular Mucinous Lobular 16 ST MIX ST MIX ST MIX Classification of Histological Type Revised system with emphasis on concordance of recognition Pure Special Type: A classical example showing the hall mark histological features You would be confident that other pathologists would recognise this case as a pure special type The definitions used are as in the UK Guidelines and require 90% purity. Medullary Carcinoma: Worse concordance in EQA scheme BRCA 1 emerging data Medullary Like Carcinoma: Syncytial interconnecting masses Grade III Large vescicular nuclei, prominent nucleoli Lymphoid cell rich stroma Pushing/well defined margins In situ uncommon 3
4 NST with special type features (mixed): No Special Type: A tumour showing no or less than 50% special type characteristics A tumour heterogeneous in morphology with some special type characteristics (>50%, <90%) e.g. tubular differentiation. The special type should be identified as an additional feature Or have one or more characteristics of a special type but lack the full combination of features required for pure special type designation, for example a distinctive lobular infiltrative growth pattern with pleomorphic non lobular cell morphology. Rare Tumour Type: A tumour showing the features (Pure >90%) of a recognised but unusual tumour type Apocrine Invasive micropapillary Adenoid cystic Metaplastic Tubular carcinoma is known to have a favourable prognosis, but does this subtype represents a distinct type of breast carcinoma and does it behave like other low-grade luminal A type breast carcinomas? Rakha et al. J Clin Oncol 28: Assessed the clinicopathologic and molecular features and prognostic value of TC compared with grade 1 ductal carcinomas of the breast. Large well-characterized series of breast cancers 2,608 invasive carcinoma, unselected consecutive cases 212 Grade 1 ductal carcinomas 102 Tubular carcinomas TC more likely to be detected on mammographic screening, had smaller median size, and less frequently showed lymphovascular invasion. Compared with grade 1 ductal carcinoma, TC was associated with longer disease-free survival (213.25, P 0.001) and breast cancer specific survival (28.8, P 0.003). None of the patients with TC developed distant metastasis or died from the disease without an intervening recurrence as invasive carcinoma of different histologic type Rakha et al. J Clin Oncol 28: Rakha et al. J Clin Oncol 28:
5 Conclusion The biologic behaviour of TC is excellent and is more favourable than that of grade 1 ductal carcinoma. Patients with TC may be at risk of developing second primary carcinomas in the contralateral breast, which may be of higher grade and poorer potential prognostic outcome. Patients with TC have a close to normal life expectancy, and as a consequence, adjuvant systemic therapy may not be justified in their routine management. Allele Loss in Breast Carcinoma 1p 1q 3p 6q 7q 8p 11p 11q 13q 16q 17p 17q 18q Rakha et al. J Clin Oncol 28: Allele Loss in Tubular Carcinoma E Cadherin Lobular Carcinoma High LOH: 3p 11q 13q 16q FHIT ATM? Man et al Cancer Research 1996, 56: 5484?Common Precursor LOH 16q C-erbB-2 & p53 Low Grade Carcinoma High Grade Carcinoma Other candidates: BRCA 1 17q Medullary BRCA 2 13q Tub & Lob 1q 3p 11q 13q 17q Tubular?Common Precursor E Cadherin LOH 16q Lobular Carcinoma Lobular Ductal Low Grade Carcinoma?Common Precursor E Cadherin 16q LOH 16q Lobular Carcinoma Low Grade Carcinoma C-erbB-2 & p53 High Grade Carcinoma C-erbB-2 & p53 High Grade Carcinoma 17q 5
6 Class 1?Common Precursor E Cadherin 16q LOH 16q Lobular Carcinoma Low Grade Carcinoma Class 2 C-erbB-2 & p53 17q High Grade Carcinoma Genome plots of the previous case FEA Cyclin D1 DCIS Cyclin D1 Cyclin D1 LN 6
7 Conclusion ER neg ER pos Luminal Type A lesions Luminal ck ER rich HER2 neg 16q del ADH/ Low Grade DCIS CCLs ALH/ LCIS Sorlie, et al. PNAS 2001 LOW GRADE NEOPLASIA FAMILY Cribriform TUBULAR G1 IDC TUBULOLOBULAR ILC Basal-like/ TN vs special types Mucinous Neuroendocrine Micropapillary Papillary Do special types of breast cancer have distinct molecular subtypes? Medullary Metaplastic Secretory Adenoid cystic Apocrine Pleomorphic lobular Acinic Reis-Filho et al., Histopathology 2006; Rakha E, Reis-Filho JS, Ellis IO. JCO, 2008; Lae et al. Mod Pathol 2008; Weiget et al., J Pathol 2008; Weigelt et al., Breast Cancer Res Treat 2009; Weigelt et al. Nat Rev Clin Oncol 2009 Special types of breast cancer are more homogeneous at the transcriptome level Luminal Basal-like Mol apocrine N=113 (11 special types of breast cancer) Operon arrays 24,650 genes TMAs 22 markers Mucinous A Classic ILC/ Tubular Mucinous B Neuroendocrine Micropapillary Adenoid cystic Medullary Metaplastic Pleomorphic ILC Apocrine Weigelt et al. J Pathol
8 Special types vs molecular subtypes IDC Osteoclastic Luminal Neuroendocrine Mucinous Tubular HER2 Classic ILC Micropapillary Apocrine Molecular apocrine Pleomorphic ILC Adenoid cystic Basal-like Medullary Claudin low? Metaplastic Reis-Filho et al., Histopathology 2006; Rakha, Reis-Filho & Ellis. JCO, 2008; Weiget et al., J Pathol 2008; Weigelt et al., Breast Cancer Res Treat 2009; Weigelt et al. Mod Pathol 2009; Weigelt et al. Nat Rev Clin Oncol 2009; Weigelt et al. J Pathol 2010 Take home messages Each special type of breast cancer is more homogeneous at the molecular level Luminal phenotype: Tubular, classic lobular, neuroendocrine and mucinous Basal-like phenotype: Medullary, metaplastic, secretory and adenoid cystic Molecular apocrine and HER2 phenotype: Apocrine and pleomorphic lobular carcinomas The integrative subgroups have distinct copy number profiles The integrative subgroups have distinct clinical outcomes 8
9 The integrative subgroups have distinct clinical outcomes IntClust 2 ER positive, poor prognosis 11q13/14 cis-acting tumours CCND1 (11q13.3), EMSY (11q113.5), PAK1 (11q14.1), RSF1 (11q14.1) 11q13/14 amplicon(s) IntClust 3 Low genetic instability Luminal A predominant Good prognoses types (tubular, lobular) Conclusions Breast cancer classification system with clinical relevance will be based on: morphology phenotype molecular genetics Routine provision of prognostic and predictive information Gene profiles can provide prognostic and predictive information and some are validated for clinical use Gene profile methods can be translated to alternative simpler methods which appear equally effective Conclusions Next generation molecular methods are likely to provide greater insight Translation of research techniques / methods to routine clinical practice are to be expected Robust validated & standardised routine methods Quality assurance integrated into service provision Pathology has a central role - analytical & coordination Decision making support systems will be essential 9
10 10
Morphological and Molecular Typing of breast Cancer
Morphological and Molecular Typing of breast Cancer Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology, Nottingham University Hospitals NHS Trust Histological
More informationCarcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS
Carcinoma mammario: le istologie non frequenti Valentina Guarneri Università di Padova IOV-IRCCS Histological diversity of breast adenocarcinomas Different histological types are defined according to specific
More informationMolecular classification of breast cancer implications for pathologists. Sarah E Pinder
Molecular classification of breast cancer implications for pathologists Sarah E Pinder Courtesy of CW Elston Histological types Breast Cancer Special Types 17 morphological special types 25-30% of all
More informationXXV Congreso de la Sociedad Española de Anatomía Patológica y División Española de la International Academy of Pathology
XXV Congreso de la Sociedad Española de Anatomía Patológica y División Española de la International Academy of Pathology NUEVOS FENOTIPOS DEL CÁNCER DE MAMA: NUEVOS PROBLEMAS PARA EL PATÓLOGO? Tienen actualmente
More informationEnterprise Interest None
Enterprise Interest None What are triple negative breast cancers? A synopsis of their histological patterns Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology,
More informationSurgical Pathology Issues of Practical Importance
Surgical Pathology Issues of Practical Importance Anne Moore, MD Medical Oncology Syed Hoda, MD Surgical Pathology The pathologist is central to the team approach needed to manage the patient with breast
More informationBasement membrane in lobule.
Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.
More informationModern classification of breast cancer-should we stick with morphology or convert to molecular profiles?
Modern classification of breast cancer-should we stick with morphology or convert to molecular profiles? Ian Ellis Professor of Cancer Pathology Molecular Medical Sciences University of Nottingham Dept
More informationRare types of breast carcinoma
Open Med. 2015; 10: 92-96 Research Article Open Access Daiva Gudaviciene*, Laura Steponaviciene, Raimundas Meskauskas, Giedre Smailyte, Eduardas Aleknavicius Rare types of breast Abstract: Breast cancer
More informationQuestion 1 A. ER-, PR-, HER+ B. ER+, PR+, HER2- C. ER-, PR+, HER2- D. ER-, PR-, HER2- E. ER-, PR+, HER2+
Triple Negative Breast Cancer Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA Question 1 The tumor depicted on the next slide
More informationTriple Negative Breast Cancer
Triple Negative Breast Cancer Prof. Dr. Pornchai O-charoenrat Division of Head-Neck & Breast Surgery Department of Surgery Faculty of Medicine Siriraj Hospital Breast Cancer Classification Traditional
More informationRare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence
Rare Breast Tumours 1. Breast Tumours 1.1 General Results Table 1. Epithelial Tumours of Breast: Incidence, Trends, Survival Flemish Region 2001-2010 Incidence Trend Survival Females EAPC Relative survival
More informationFISH mcgh Karyotyping ISH RT-PCR. Expression arrays RNA. Tissue microarrays Protein arrays MS. Protein IHC
Classification of Breast Cancer in the Molecular Era Susan J. Done University Health Network, Toronto Why classify? Prognosis Prediction of response to therapy Pathogenesis Invasive breast cancer can have
More informationPresent Role of Immunohistochemistry in the. Subtypes. Beppe Viale European Institute of Oncology University of Milan Milan-Italy
Present Role of Immunohistochemistry in the Classification of Molecular Subtypes Beppe Viale European Institute of Oncology University of Milan Milan-Italy We know it is many diseases Breast cancer is
More informationProtocol for the Examination of Biopsy Specimens From Patients With Invasive Carcinoma of the Breast
Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast Version: BreastInvasive 1.0.0.0 Protocol Posting Date: February 2019 Accreditation Requirements The use of
More informationRecent advances in breast cancers
Recent advances in breast cancers Breast cancer is a hetrogenous disease due to distinct genetic alterations. Similar morphological subtypes show variation in clinical behaviour especially in response
More informationMaram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine
Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine The most common non-skin malignancy of women 2 nd most common cause of cancer deaths in women, following
More informationContents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ
Contents 1 The Windows of Susceptibility to Breast Cancer... 1 1.1 Introduction... 1 1.2 Risk Factor and Etiological Agents... 2 1.3 The Concept of the Windows of Susceptibility to Carcinogenesis... 5
More informationEpithelial Columnar Breast Lesions: Histopathology and Molecular Markers
29th Annual International Conference Advances in the Application of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells 25 th -27t h June, 2012, Mykonos, Greece Epithelial Columnar
More informationColumnar Cell Lesions
Columnar Cell Lesions Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Question? Columnar cell lesions are: a) Annoying lesions
More informationProliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease
Proliferative Breast Disease: implications of core biopsy diagnosis Jean F. Simpson, M.D. Breast Pathology Consultants, Inc. Nashville, TN Proliferative Breast Disease Must be interpreted in clinical and
More informationPapillary Lesions of the breast
Papillary Lesions of the breast Emad Rakha Professor of Breast Pathology The University of Nottingham Papillary lesions of the breast are a heterogeneous group of disease, which are characterised by neoplastic
More informationDisclosures 5/27/2012. Outline of Talk. Outline of Talk. When Is LCIS Clinically Significant? Classic LCIS. Classic LCIS
When Is LCIS Clinically Significant? Disclosures I have nothing to disclose Yunn-Yi Chen, MD, PhD Professor Outline of Talk Outline of Talk Classic LCIS Classic LCIS Definition of lobular differentiation
More informationCLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES
Papillomas. Papillomas are composed of multiple branching fibrovascular cores, each having a connective tissue axis lined by luminal and myoepithelial cells ( Fig. 23-11 ). Growth occurs within a dilated
More informationThe management of B3 lesions with emphasis on lobular neoplasia
The management of B3 lesions with emphasis on lobular neoplasia Abeer Shaaban Queen Elizabeth Hospital Birmingham NHSBSP core biopsy categories B1 - Normal B2 - Benign B3 Uncertain malignant potential
More informationBreast pathology. 2nd Department of Pathology Semmelweis University
Breast pathology 2nd Department of Pathology Semmelweis University Breast pathology - Summary - Benign lesions - Acute mastitis - Plasma cell mastitis / duct ectasia - Fat necrosis - Fibrocystic change/
More informationUniversity of Zurich. Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice and Pitfalls. Zurich Open Repository and Archive
University of Zurich Zurich Open Repository and Archive Winterthurerstr. 190 CH-8057 Zurich http://www.zora.uzh.ch Year: 2009 Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice
More informationLOBULAR CARCINOMA IN SITU: WHAT DOES IT MEAN? THE SURGEON'S PERSPECTIVE
: WHAT DOES IT MEAN? THE SURGEON'S PERSPECTIVE Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University of Washington Joint Member, Fred Hutchinson Cancer
More information6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies
Outline of Talk Lobular Breast Cancer: Common Problems in Diagnosing LCIS in Core Biopsies Definition of lobular differentiation Variants of LCIS that: carry risk for unsampled invasive cancer mimic DCIS
More informationCase 1. ACCME/Disclosure. Clinical History. Dr. Mulligan has nothing to disclose
Breast Evening Specialty Conference USCAP, 2016 Case 1 Anna Marie Mulligan University Health Network, Toronto University of Toronto ACCME/Disclosure Dr. Mulligan has nothing to disclose Clinical History
More informationColumnar Cell Lesions. Columnar Cell Lesions and Flat Epithelial Atypia
Columnar Cell Lesions and Stuart J. Schnitt, M.D. Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA, USA Columnar Cell Lesions Lesions characterized by columnar epithelial cells
More informationDuctal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA
Ductal Carcinoma in Situ Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Definition of DCIS WHO 2012 A neoplastic proliferation
More informationPathology of Lobular & Ductal Preneoplasia. Syed A Hoda, MD Weill-Cornell, New York, NY
Pathology of Lobular & Ductal Preneoplasia Syed A Hoda, MD Weill-Cornell, New York, NY Proliferative Epithelial Changes in Breast A wide range of proliferative epithelial changes occur in the breast There
More informationUniversity Journal of Pre and Para Clinical Sciences
ISSN 2455 2879 Volume 2 Issue 1 2016 Metaplastic carcinoma breast a rare case report Abstract : Metaplastic carcinoma of the breast is a rare malignancy with two distinct cell lines described as a breast
More informationDiagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Pathology. AGO e. V. in der DGGG e.v. sowie in der DKG e.v.
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Pathology Pathology Versions 2004 2017: Blohmer / Costa / Fehm / Friedrichs / Huober / Kreipe / Lück / Schneeweis / Sinn /
More information10/15/2012. Biologic Subtypes of TNBC. Topics. Topics. Histopathology Molecular pathology Clinical relevance
Biologic Subtypes of TNBC Andrea L. Richardson M.D. Ph.D. Brigham and Women s Hospital Dana-Farber Cancer Institute Harvard Medical School Boston, MA Topics Histopathology Molecular pathology Clinical
More informationTreatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea
Treatment options for the precancerous Atypical Breast lesions Prof. YOUNG-JIN SUH The Catholic University of Korea Not so benign lesions? Imaging abnormalities(10% recall) lead to diagnostic evaluation,
More informationImmunohistochemical classification of breast tumours
Immunohistochemical classification of breast tumours Workshop in Diagnostic Immunohistochemistry September 19 th - 21 th 2018 Anne-Vibeke Lænkholm Department of Surgical Pathology, Zealand University Hospital,
More informationBreast cancer classification: beyond the intrinsic molecular subtypes
Breast cancer classification: beyond the intrinsic molecular subtypes Britta Weigelt, PhD Signal Transduction Laboratory CRUK London Research Institute Summary Breast cancer heterogeneity Molecular classification
More information04/10/2018 HIGH RISK BREAST LESIONS. Pathology Perspectives of High Risk Breast Lesions ELEVATED RISK OF BREAST CANCER HISTORICAL PERSPECTIVES
Pathology Perspectives of High Risk Breast Lesions Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head Director of Clinical Trials, Research and Development The University of Texas MD
More informationSlide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana
Slide seminar Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana Case 5 A 57-year-old man with a dermal/subcutaneous lesion on the scalp, which was interpreted
More informationBasal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up ...
21 ORIGINAL ARTICLE Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up A J Evans, E A Rakha, S E Pinder, A R Green, C Paish and I O Ellis...
More informationPapillary Lesions of the Breast
Papillary Lesions of the Breast Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical Center and Harvard Medical School
More information3/27/2017. Disclosure of Relevant Financial Relationships. Papilloma???
Management of Papillary Lesions Diagnosed at Rad Path Concordant Core Biopsy (CNB) Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to
More informationLYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR
BREAST LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR HISTOLOGY LOBE: (10 in whole breast) LOBULE: (many per lobe) ACINUS/I, aka ALVEOLUS/I: (many per lobule) DUCT(S): INTRA- or
More informationProliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London
Proliferative Epithelial lesions of the Breast Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London Amman, November2013 Proliferative Epithelial Lesions of the Breast Usual type
More informationIntraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance
& 2006 USCAP, Inc All rights reserved 0893-3952/06 $30.00 www.modernpathology.org Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance Charles C Guo 1 and
More informationColumnar Cell Lesions and Flat Epithelial Atypia
Columnar Cell Lesions and Flat Epithelial Atypia Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA Terminology for Columnar Cell
More information04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA
Intraductal Papillary Neoplasms Of Breast Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head The University of Texas MD Anderson Cancer Center 25 th Annual Seminar in Pathology Pittsburgh,
More informationDiseases of the breast (2 of 2) Breast cancer
Diseases of the breast (2 of 2) Breast cancer Epidemiology & etiology The most common type of cancer & the 2 nd most common cause of cancer death in women 1 of 8 women in USA Affects 7% of women Peak at
More informationSentinel nodes. Location: Location: S1.04 Principal clinician. G1.01 Record other relevant information. S2.01 Number of specimens submitted
Invasive Breast Cancer Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given name(s) Date of birth DD MM YYYY
More informationBreast Pathology. Breast Development
Breast Pathology Lecturer: Hanina Hibshoosh, M.D. Reading: Kumar, Cotran, Robbins, Basic Pathology, 6th Edition, pages 623-635 Breast Development 5th week - thickening of the epidermis - milk line 5th
More informationUK Interdisciplinary Breast Cancer Symposium. Should lobular phenotype be considered when deciding treatment? Michael J Kerin
UK Interdisciplinary Breast Cancer Symposium Should lobular phenotype be considered when deciding treatment? Michael J Kerin Professor of Surgery National University of Ireland, Galway and Galway University
More informationMolecular Characterization of Breast Cancer: The Clinical Significance
Molecular Characterization of : The Clinical Significance Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine-Jacksonville
More informationGood afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting
PATHOLOGY IN-SITU CARCINOMA, ROHIT BHARGAVA, MD 1 Good afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting me here, it s great to be here and I m going to talk about
More informationThe 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach
The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach Dr. Carol Farver Director, Pulmonary Pathology Pathology and Laboratory Medicine Institute Objectives Discuss
More informationNEUROENDOCRINE DIFFERENTIATED BREAST CARCINOMA
+ NEUROENDOCRINE DIFFERENTIATED BREAST CARCINOMA + INTRODUCTION + NEUROENDOCRINE FEATURES IN BREAST CARCINOMA Incidence of 2-5% Seen in various histopathological types of breast carcinoma Seen in both
More informationHeterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome
Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome Emilia Montagna, 1 Patrick Maisonneuve, 2 Nicole Rotmensz, 2 Giuseppe Cancello, 1 Monica Iorfida, 1 Alessandra
More informationUSCAP 2012: Companion Meeting of the AAOOP. Update on lacrimal gland neoplasms: Molecular pathology of interest
USCAP 2012: Companion Meeting of the AAOOP Vancouver BC, Canada, March 17, 2012 Update on lacrimal gland neoplasms: Molecular pathology of interest Valerie A. White MD, MHSc, FRCPC Department of Pathology
More informationBMaP-3 Cancer Database. Aggregate Data File
BMaP-3 Cancer Database Aggregate Data File Contents BMaP-3 Cancer Database... 1 Aggregate Data File... 1 Frequency Tables... 2 Institution... 2 Year_First_Contact... 2 Primary_Site... 3 Sex... 3 Race...
More informationCME. CK5 Is More Sensitive Than CK5/6 in Identifying the Basal-like Phenotype of Breast Carcinoma
Anatomic Pathology / CK5 vs CK5/6 in Breast Carcinoma CK5 Is More Sensitive Than CK5/6 in Identifying the Basal-like Phenotype of Breast Carcinoma Rohit Bhargava, MD, 1 Sushil Beriwal, MD, 2 Kim McManus,
More informationPATHOBIOLOGICAL PREDICTORS OF BEHAVIOUR IN INVASIVE LOBULAR CARCINOMA OF THE BREAST. CHEOK POH YIAN (B.Sc., NUS) A THESIS SUBMITTED FOR THE DEGREE OF
PATHOBIOLOGICAL PREDICTORS OF BEHAVIOUR IN INVASIVE LOBULAR CARCINOMA OF THE BREAST CHEOK POH YIAN (B.Sc., NUS) A THESIS SUBMITTED FOR THE DEGREE OF MASTER OF SCIENCE DEPARTMENT OF ANATOMY NATIONAL UNIVERSITY
More informationLesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node
Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node Oil Cyst Mass, Intermediate Concern Microlobulated Margins Obscured Margins Mass, Favoring Malignant Indistinct
More informationLesions Mimicking Adenoid Cystic Carcinoma. Diagnostic Problems in Salivary Gland Pathology An Update 5/29/2009
Diagnostic Problems in Salivary Gland Pathology An Update Lesions Mimicking Adenoid Cystic Carcinoma Stacey E. Mills, M.D. W.S. Royster Professor of Pathology Director of Surgical and Cytopathology University
More informationPost Neoadjuvant therapy: issues in interpretation
Post Neoadjuvant therapy: issues in interpretation Disclosure: Overview D Prognostic features in assessment of post treatment specimens: Tumor size Cellularity Grade Receptors LN Neoadjuvant chemotherapy:
More informationQuality Assurance and Quality Control in the Pathology Dept.
Quality Assurance and Quality Control in the Pathology Dept. Judith Sandbank M.D. Pathology Assaf-Harofeh Medical Center ISRAEL jsandbank@asaf.health.gov.il 2 nd IBDC, 9 th February, 2012 Pathology as
More informationReporting of Breast Cancer Do s and Don ts
Reporting of Breast Cancer Do s and Don ts 7 th SGH Annual Breast Pathology Course Professor Michael Bilous Conjoint Professor Western Sydney University Consultant Pathologist, Australian Clinical Labs,
More informationPapillary Lesions of the Breast: WHO Update
Papillary Lesions of the Breast: WHO Update Stuart J. Schnitt, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA, USA Papillary Lesions of the Breast
More informationFlat Epithelial Atypia
Flat Epithelial Atypia Richard Owings, M.D. University of Arkansas for Medical Sciences Department of Pathology Flat epithelial atypia can be a difficult lesion May be a subtle diagnosis Lots of changes
More informationHistological types of breast cancer: How special are they?
MOLECULAR ONCOLOGY 4 (2010) 192e208 available at www.sciencedirect.com www.elsevier.com/locate/molonc Review Histological types of breast cancer: How special are they? Britta Weigelt a, Felipe C. Geyer
More informationARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.
1 ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY Jonathan I. Epstein Professor Pathology, Urology, Oncology The Reinhard Professor of Urological
More informationINTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein
INTRADUCTAL LESIONS OF THE PROSTATE Jonathan I. Epstein Topics Prostatic intraepithelial neoplasia (PIN) Intraductal adenocarcinoma (IDC-P) Intraductal urothelial carcinoma Ductal adenocarcinoma High Prostatic
More informationDecember 2002 Monthly Memo
FLORIDA CANCER DATA SYSTEM December 2002 Monthly Memo CODING COMPLEX MORPHOLOGIC DIAGNOSES CODING COMPLEX BREAST HISTOLOGIES Apply these guidelines in priority order. Use the first guideline that applies
More informationMy Personalized Breast Cancer Worksheet
My Personalized Breast Cancer Worksheet KNOW For Early-Stage Breast Cancer. No Questions. Only Results. No two tumors are alike. What are the characteristics of your breast cancer and how will that effect
More informationUpdate in Salivary Gland Pathology. Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016
Update in Salivary Gland Pathology Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016 Objectives Review the different appearances of a selection of salivary gland tumor types Establish
More informationFlat Epithelial Atypia: A Review of Current Concepts
90 The Open Breast Cancer Journal, 2010, 2, 90-94 Flat Epithelial Atypia: A Review of Current Concepts Amy L. Adams * Open Access Department of Pathology and Laboratory Medicine, Emory University School
More informationCase study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research
NCCN/JCCNB Seminar in Japan April 15, 2012 Case study 1 Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research Present illness: A 50y.o.premenopausal
More informationCLINICOPATHOLOGIC FEATURES AND MOLECULAR SUBTYPES OF BREAST CANCER IN FEZ-MEKNES REGION (MOROCCO): A STUDY OF 390 PATIENTS
CLINICOPATHOLOGIC FEATURES AND MOLECULAR SUBTYPES OF BREAST CANCER IN FEZ-MEKNES REGION (MOROCCO): A STUDY OF 390 PATIENTS S. Chahbouni¹, A. Amarti 2, N. Hammas 3, L. Chbani 3, H. El fatemi 3 1 Department
More informationSalivary Glands 3/7/2017
Salivary Glands 3/7/2017 Goals and objectives Focus on the entities unique to H&N Common board type facts Information for your future practice Salivary Glands Salivary Glands Major gland. Paratid. Submandibular.
More informationCPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast.
CPC 4 Breast Cancer Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast. 1. What are the most likely diagnoses of this lump? Fibroadenoma
More informationSynchronous squamous cell carcinoma of the breast. and invasive lobular carcinoma
Sentani K et al. 1 Letter to the editor Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma Kazuhiro Sentani, 1 Takashi Tashiro, 2 Naohide Oue, 1 Wataru Yasui 1 1 Department
More informationACRIN 6666 Therapeutic Surgery Form
S1 ACRIN 6666 Therapeutic Surgery Form 6666 Instructions: Complete a separate S1 form for each separate area of each breast excised with the intent to treat a cancer (e.g. each lumpectomy or mastectomy).
More informationIncidence of ductal lesions
Ductal Proliferative Lesions of the Breast: From FEA to ADH to DCIS Incidence of ductal lesions Pre-mammography: DCIS < 3% of breast cancers, large palpable masses, with invasion Mammography: DCIS 25%
More informationShort Term Cancer Risk
in a Cohort of 2312 Women with High Risk Breast Lesions Kubat E 1, Puligandla B 2, Collins L 3, Jiang SF 4, Callahan M 5, Kutner S 6, Habel L 4, Shim V 1 1 Surgery, Kaiser Permanente, Oakland, CA; 2 Pathology,
More informationBIOLOGICAL AND CLINICAL CHARACTERISTICS OF INVASIVE DUCTAL CARCINOMA WITH LOBULAR PATTERN
BIOLOGICAL AND CLINICAL CHARACTERISTICS OF INVASIVE DUCTAL CARCINOMA WITH LOBULAR PATTERN Final Degree Project Author: Kyong Bok Rodríguez Rausis Tutor: Cristina Melendez Muñoz FACULTY OF MEDICINE January
More informationBreast Cancer 100: Overview of Breast Cancer in Native Americans
Breast Cancer 100: Overview of Breast Cancer in Native Americans Native American Cancer Research A Native operated non-profit corporation 3022 South Nova Road Pine, CO 80470-7830 Phone: 303-838-9359 Fax:
More informationBreast cancer: Molecular STAGING classification and testing. Korourian A : AP,CP ; MD,PHD(Molecular medicine)
Breast cancer: Molecular STAGING classification and testing Korourian A : AP,CP ; MD,PHD(Molecular medicine) Breast Cancer Theory: Halsted Operative breast cancer is a local-regional disease The positive
More informationIn situ lobular neoplasia of the breast with marked myoepithelial proliferation
In situ lobular neoplasia of the breast with marked myoepithelial proliferation Sami Shousha To cite this version: Sami Shousha. In situ lobular neoplasia of the breast with marked myoepithelial proliferation.
More informationReview Article. Is Basal-like Carcinoma of the Breast a Distinct Clinicopathologic Entity? A Critical Review with Cautionary Notes.
Iranian Journal of Pathology (2007)2 (4), 127-143 127 Review Article Is Basal-like Carcinoma of the Breast a Distinct Clinicopathologic Entity? A Critical Review with Cautionary Notes Farid Moinfar Unit
More informationPromise of a beautiful day
Promise of a beautiful day Ductal carcinoma in Situ Lobular Carcinoma in Situ Natural History Manosmed Tartous Oct 2009 Gérard ABADJIAN MD Pathology Department Hôtel-Dieu de France. Associate Professor
More informationProperties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.12.4921 Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up RESEARCH ARTICLE Properties of Synchronous Versus Metachronous
More informationIBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina
Preoperative diagnosis and treatment planning in breast cancer The pathologist s perspective L. Mazzucchelli Istituto Cantonale di Patologia Locarno, Switzerland IBCM 2, 23-25 April 2009, Sarajevo, Bosnia
More informationImage guided core biopsies:
Recommendations on the Surgical, Radiologic and Pathologic Approaches to Breast Disease: Using best practices based on multidisciplinary methodologies developed through the Allina Breast Committee. Image
More informationNotice of Faculty Disclosure
California Society of Pathology Diagnostic Problems in Surgical Pathology December 2015 Case 2 Laura C. Collins, M.D. Associate Professor of Pathology Associate Director of Anatomic Pathology Beth Israel
More informationInvasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases
Virchows Arch (2006) 449:507 512 DOI 10.1007/s00428-006-0305-3 ORIGINAL ARTICLE Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns
More informationGábor CSERNI. 1. Bács-Kiskun County Teaching Hospital, Kecskemét 2. University of Szeged, Szeged
Lymphocytes infiltrant la tumeur (TIL) sur micro-biopsies et pièces opératoires Quel impact clinique? Quels moyens de mise en évidence? Comment restituer les résultats? TILs - Clinical impact / Evaluation
More informationMinimizing Errors in Diagnostic Pathology
Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine-Jacksonville Medical Director, Shands Jacksonville Breast Health Center
More informationTitle malignancy. Issue Date Right 209, 12, (2013)
NAOSITE: Nagasaki University's Ac Title Author(s) A case of intracystic apocrine papi malignancy Hayashi, Hiroko; Ohtani, Hiroshi; Y Citation Pathology - Research and Practice, Issue Date 2013-12 URL Right
More informationCURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY
CURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY JULY, 2003 The following is a conceptual curriculum and set of guidelines for Pathology Residents on the Breast
More informationPapillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.
Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,
More information